Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

Moreno FA, Wiegand CB, Taitano EK, Delgado PL

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (70)

    1. Study participant perceptions of the relevance of therapist and study team personal psychedelic experience 2026-10-03 · Expand citations
    2. A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults 2026-09-21 · Expand citations
    3. Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review 2026-07-26 · Expand citations
    4. Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review 2026-07-01 · Expand citations
    5. Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
    6. Psilocybin: Chemical Foundations and Emerging Therapeutic Potential 2026-06-01 · Expand citations
    7. A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder 2026-05-01 · Expand citations
    8. Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins 2026-04-21 · Expand citations
    9. Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
    10. Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework 2026-03-31 · Expand citations
    11. Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons 2026-03-27 · Expand citations
    12. “You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice 2026-03-22 · Expand citations
    13. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    14. Acute psilocin increased cortical activity in rat 2026-02-04 · Expand citations
    15. Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress 2026-01-02 · Expand citations
    16. Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence 2025-10-27 · Expand citations
    17. Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms 2025-07-22 · Expand citations
    18. Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns 2025-07-16 · Expand citations
    19. Explore the effect of psilocybin on depression and anxiety 2025-07-06 · Expand citations
    20. Is there mush-room to improve the environmental sustainability of psilocybin production? 2025-06-10 · Expand citations
    21. Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling 2025-06-01 · Expand citations
    22. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung 2025-05-01 · Expand citations
    23. Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans 2025-04-21 · Expand citations
    24. Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing? 2025-03-21 · Expand citations
    25. Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications 2025-03-07 · Expand citations
    26. BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations
    27. Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners 2025-02-05 · Expand citations
    28. The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin 2024-11-01 · Expand citations
    29. Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy 2024-10-09 · Expand citations
    30. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms 2024-09-09 · Expand citations
    31. Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports 2024-07-17 · Expand citations
    32. Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30) 2024-07-12 · Expand citations
    33. Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare 2024-06-28 · Expand citations
    34. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin 2024-04-29 · Expand citations
    35. Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice 2024-01-25 · Expand citations
    36. Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge 2023-12-30 · Expand citations
    37. The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review 2023-11-29 · Expand citations
    38. Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol 2023-10-25 · Expand citations
    39. Pharmacology and Therapeutic Effects of Psilocybin 2023-08-29 · Expand citations
    40. use of psilocybin in the treatment of psychiatric disorders - review 2023-08-15 · Expand citations
    41. Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands 2023-01-16 · Expand citations
    42. Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights 2023-01-09 · Expand citations
    43. A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness 2023-01-01 · Expand citations
    44. P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications 2022-09-01 · Expand citations
    45. Insights for Modern Applications of Psilocybin Therapy from a Case Study of Traditional Mazatec Medicine 2022-08-14 · Expand citations
    46. Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin 2022-06-01 · Expand citations
    47. The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis 2022-05-15 · Expand citations
    48. An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma 2022-01-01 · Expand citations
    49. Unravelling a New Conformer of Psilocin Through Computational Methods 2022-01-01 · Expand citations
    50. P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study 2021-12-01 · Expand citations
    51. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey 2021-11-03 · Expand citations
    52. A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing 2021-09-16 · Expand citations
    53. The therapeutical role of psychedelic drugs in treatment of mental disorders 2021-09-15 · Expand citations
    54. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa 2021-06-24 · Expand citations
    55. Effectiveness of Psilocybin on Depression: A Qualitative Study 2021-04-27 · Expand citations
    56. Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands 2021-04-16 · Expand citations
    57. ‘Is There Magic in These Mushrooms?’ Discussing Current Psychiatric Treatment Options, and the Potential of Psilocybin Mushrooms in the Future of Such Treatments 2021-04-03 · Expand citations
    58. Use of psilocybin (“mushrooms”) among US adults: 2015-2018 2021-02-04 · Expand citations
    59. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma 2021-02-01 · Expand citations
    60. Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy 2020-11-10 · Expand citations
    61. Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin 2020-07-14 · Expand citations
    62. A potential role for psilocybin in the treatment of obsessive-compulsive disorder 2020-06-01 · Expand citations
    63. Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats 2018-09-01 · Expand citations
    64. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
    65. Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance 2017-01-02 · Expand citations
    66. Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats 2015-01-01 · Expand citations
    67. The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat 2014-05-16 · Expand citations
    68. Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are Overrated 2014-02-01 · Expand citations
    69. Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care Professionals 2009-12-31 · Expand citations
    70. Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder 2008-01-01 · Expand citations